Ultragenyx Pharmaceutical (RARE) Q3 2020 Earnings

30JulConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-1.96
-1.17
-0.38
0.41

Details

Expected EPS
-1.58
Actual EPS
0.41
Surprise EPS
1.99
Surprise Percent
+125.95%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of 0.41 per share for Q3 2020.

0 Comments

Share your thoughts